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Abstract
Purpose: CT ventilation imaging (CTVI) is being used to achieve functional avoidance lung
cancer radiation therapy in three clinical trials (NCT02528942, NCT02308709, NCT02843568). To
address the need for common CTVI validation tools, we have built the Ventilation And Medical65
Pulmonary Image Registration Evaluation (VAMPIRE) Dataset, and present the results of the
first VAMPIRE Challenge to compare relative ventilation distributions between different CTVI
algorithms and other established ventilation imaging modalities.
Methods: The VAMPIRE Dataset includes 50 pairs of 4DCT scans and corresponding clinical or
experimental ventilation scans, referred to as reference ventilation images (RefVIs). The dataset70
includes 25 humans imaged with Galligas 4DPET/CT, 21 humans imaged with DTPA-SPECT
and 4 sheep imaged with Xenon-CT. For the VAMPIRE Challenge, 16 subjects were allocated to
a training group (with RefVI provided) and 34 subjects were allocated to a validation group (with
RefVI blinded). 7 research groups downloaded the Challenge dataset and uploaded CTVIs based
on deformable image registration (DIR) between the 4DCT inhale/exhale phases. Participants75
used DIR methods broadly classified into B-splines, Free-form, Diffeomorphisms or Biomechanical
modeling, with CT ventilation metrics based on the DIR evaluation of volume change, Hounsfield
Unit change, or various hybrid approaches. All CTVIs were evaluated against the corresponding
RefVI using the voxel-wise Spearman coefficient rS, and Dice similarity coefficients evaluated for
low function lung (DSClow) and high function lung (DSChigh).80
Results: A total of 37 unique combinations of DIR method and CT ventilation metric were either
submitted by participants directly or derived from participant-submitted DIR motion fields using
the in-house software, VESPIR. The rS and DSC results reveal a high degree of inter-algorithm
and inter-subject variability among the validation subjects, with algorithm rankings changing by
up to 10 positions depending on the choice of evaluation metric. The algorithm with the highest85
overall cross-modality correlations used a biomechanical model based DIR with a hybrid ventilation
metric, achieving a median (range) of 0.49 (0.27-0.73) for rS, 0.52 (0.36-0.67) for DSClow and 0.45
(0.28-0.62) for DSChigh. All other algorithms exhibited at least one negative rS value, and/or one
DSC value less than 0.5.
Conclusions: The VAMPIRE Challenge results demonstrate that the cross-modality correlation90
between CTVIs and the RefVIs vary not only with the choice of CTVI algorithm, but also with
the choice of RefVI modality, imaging subject, and the evaluation metric used to compare relative
4
ventilation distributions. This variability may arise from the fact that each of the different CTVI
algorithms and RefVI modalities provides a distinct physiologic measurement. Ultimately this
variability, coupled with the lack of a ‘gold standard,’ highlight the ongoing importance of further95
validation studies before CTVI can be widely translated from academic centers to the clinic. It is
hoped that the information gleaned from the VAMPIRE Challenge can help inform future validation
efforts.
∗ Author to whom correspondence should be addressed. Electronic mail: john.kipritidis@health.nsw.gov.au;
Telephone: +61 (02) 9463 1350
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I. INTRODUCTION
Computed tomography ventilation imaging (CTVI) is a form of image processing ap-100
plied to breathing correlated CT - a purely anatomic imaging modality - to visualize three-
dimensional distributions of breathing-induced air volume changes in the lung, i.e. “ventila-
tion”. Ventilation contributes to blood-gas exchange, the primary function of the lung, and
is one of the important surrogate markers for lung function. Ventilation is a core element in
spirometry, the most commonly used measure of lung function, and is an important imaging105
target driving the diagnosis and treatment of lung disease as a regionally heterogeneous
system [1]. CTVI has been applied to functional avoidance lung cancer radiation therapy
treatments in three US clinical trials (NCT02528942, NCT02308709, NCT02843568) on the
basis of clinical validation against clinical pulmonary function tests (spirometry) [2, 3] and
gamma scintigraphy [4]. Thus far however, it has proved difficult to establish convincing110
and reproducible voxel-level correlations between CTVI and other clinically accepted, three-
dimensional ventilation imaging modalities. With many possible CT acquisition protocols
and many different CTVI algorithms, there is a need for common validation datasets to bet-
ter establish the cross-modality (voxel-level) correlation between CTVIs and other already-
established or “reference” ventilation imaging modalities (RefVIs). To address this need,115
we have developed the multi-institutional VAMPIRE (Ventilation And Medical Pulmonary
Image Registration Evaluation) Dataset, which is drawn from three existing functional lung
imaging studies. This paper describes the rationale and structure of the VAMPIRE Dataset,
as well as the results of the VAMPIRE Challenge, which was launched in 2016 to compare
relative ventilation distributions between different CTVI algorithms and different types of120
RefVIs.
Almost all CTVI algorithms hinge on three central steps: (i) acquisition of a breathing
correlated CT scan, most commonly four-dimensional CT (4DCT [5]), and less commonly
breath hold CT (BHCT [6]) or 4D cone beam CT (4DCBCT [7]), (ii) deformable image
registration (DIR) between the inhale and exhale 4D phase images, and (iii) application of125
a ventilation metric which uses the DIR motion field to evaluate breathing-induced changes
in regional lung volume, or to evaluate regional lung density changes between the spatially
aligned exhale and inhale phase images. In describing this process, it is important to reiter-
ate that the CTVIs are not ‘acquired’ per se, rather they are computed or synthesized from
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the acquired anatomic 4DCT scan. The multitude of techniques for synthesizing ventilation130
from anatomic 4DCT (in particular, the use of different DIR methods and ventilation met-
rics) renders the outputs equally variable [8]. In order to be used in the radiation therapy
treatment planning system, the CTVI is converted to a relative ventilation distribution (e.g.
percentile map) so as to delineate functional structures or otherwise provide a continuous
distribution of functional weightings for each lung voxel [9–11].135
Many CTVI validation studies are fundamentally similar in that they involve intra-
patient comparisons between CTVI and a corresponding RefVI. Comparisons with Xenon
CT in mechanically ventilated sheep [12], and ex-vivo imaging of fluorescent microspheres
in mice [13] have featured highly controlled experimental conditions and achieved strong
cross-modality correlations (e.g. with voxel-level correlations exceeding ∼ 0.8 for small lung140
sub-volumes). In contrast, clinical human studies using single photon emission computed
tomography (SPECT) with technetium-99m (99mTc) [10, 14, 15], positron emission tomog-
raphy (PET) with gallium-68 (68Ga)[6, 16, 17], and hyperpolarized gas MRI with either
helium-3 (3He) [18] or xenon-129 (129Xe) [19] have all shown variable cross-modality correla-
tions (mean Spearman correlations in the range 0.1-0.8), which has been variously attributed145
to poor image quality in the 4DCT dataset or the RefVI scan, time delays between intra-
patient scans, or poor reproducibility of breathing patterns/manoeuvres. A recent study
by Eslick et al. [20] evaluated CTVI against Galligas PET and suggests the possibility
for substantial improvement in cross-modality correlations when the CTVI is derived from
high-quality exhale/inhale BHCT as opposed to 4DCT. The authors reasoned that this im-150
provement was due to the BHCT scans having a higher spatial resolution than the 4DCT
scans and because they were less prone to image reconstruction artefacts related to irregular
breathing. Ultimately, it is difficult to make direct comparisons between the different single-
institution studies - or to draw conclusions from those comparisons - due to the myriad of
implementation differences in DIR, ventilation metric(s), pre-/post-processing and metrics155
for comparing relative ventilation distributions.
The motivation for this work is twofold. First, we present the VAMPIRE Dataset which
focuses on the specific problem of comparing relative ventilation distributions between
CTVIs and different types of RefVIs. The dataset was constructed thanks to a collabo-
rative effort between the University of Sydney, Peter MacCallum Cancer Centre, Stanford160
University, the University of Iowa and University of Madison-Wisconsin and is derived from
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three separate functional lung imaging studies [2, 21, 22]. The dataset comprises 50 pairs
of 4DCT and RefVI scans including 25 free-breathing human subjects imaged with 68Ga-
labelled nanoparticles (Galligas) 4DPET/CT, 21 free-breathing human subjects imaged with
diethylenetriamine pentaacetate acid (DTPA) SPECT and 4 mechanically ventilated sheep165
imaged with Xenon-CT. The VAMPIRE Dataset has a minimal set of inclusion / exclusion
criteria ensuring a diverse range of healthy and diseased subjects, with a mix of different
4DCT image quality levels.
As a second part of this work, we report on the results of the VAMPIRE Challenge -
inspired by the grand challenges for DIR such as EMPIRE10 [23] and MIDRAS [24]. For170
the VAMPIRE Challenge, seven groups from the US, Europe, Asia and Oceania downloaded
the 4DCT scans - with a majority of the RefVI scans blinded - and uploaded their DIR
motion fields and processed CTVIs using their algorithm(s) of choice. We compare the
relative ventilation distributions between each CTVI and corresponding RefVI using the two
dominant evaluation metrics in the CTVI validation literature, which reflect the intended175
use of the CTVIs as relative ventilation distributions in the treatment planning system.
These metrics are the voxel-wise Spearman correlation rS evaluated over the whole lung,
and Dice similarity coefficients evaluated for low and high function lung zones (DSClow and
DSChigh, respectively). The results are stratified according to imaging protocol, DIR method
and ventilation metric.180
In presenting the results of the VAMPIRE Challenge, we should clarify a few points.
First and foremost, we must acknowledge that there exists a philosophical difference of
opinion within the field regarding the feasibility of performing clinical validation of CTVI
using DTPA-SPECT, Galligas 4DPET/CT or Xenon CT. The heart of the problem is that
these modalities measure normal tissue processes which are distinct to each other, and also185
distinct to the quantity ostensibly imaged by CTVI (distributions of breathing-induced air-
volume change). Of the reference ventilation imaging modalities in VAMPIRE, Xenon-CT
comes closest to imaging regional air volume changes directly: by analysing the dynamic
enhancement of X-ray attenuation during the wash-in/wash-out of an inert, non-ionising
gas (Xenon). DTPA-SPECT and Galligas PET both rely on the imaging of radiotracer dis-190
tributions which are inhaled and deposited in the lung prior to the scan itself, but the two
radiotracers have different physical flow properties. For example, 99mTc-labelled DTPA is a
nebulized radioaerosol featuring liquid droplets ranging from 1µm to larger than 10µm: the
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resulting deposition mechanisms include inertial impaction for the largest droplets, gravita-
tional sedimentation for mid-sized droplets, or Brownian diffusion for the smallest, most ‘gas195
like’ droplets [25] . By comparison Galligas is produced in a Techegas generator and consists
of an ultra-fine dispersion of 68Ga-labelled carbon that penetrates deeper into the non-con-
ducting airways due to its sub-µm size [21, 25]. Since Xenon gas, 99mTc-labelled DTPA
and 68Ga-labelled carbon are all surrogates for air, the VAMPIRE Challenge is faced with
the difficulty of lacking an incontrovertible ‘ground truth’. Additionally, our study is not200
geared to evaluate the DIR numerical stability, short-term reproducibility or the underlying
physiologic bases for any of the modalities investigated. The importance of these issues has
been raised by a number of theoretical [26] and experimental [7, 27–29] studies, as well as
in review papers [1, 25, 30]. We will touch on these issues in the Discussion section.
With these issues in mind, we note that the VAMPIRE Dataset and Challenge cannot205
make a definitive statement about the spatial distribution of physiologic accuracy for any
one CTVI algorithm, or for CTVI generally. Indeed, one could argue that our comparison
of relative ventilation distributions in terms of the rS, DSChigh and DSClow metrics provides
a necessary - but not fully sufficient - set of criteria to characterize the cross-modality cor-
relations. Instead, we emphasise that the true value of this work is in recognising the rich210
variety in outputs between different CTVI algorithms as implemented by different groups,
to present an initial case study of cross-modality correlations generated in a multi-institu-
tional setting, and to provide an on-line dataset that is a useful resource for future CTVI
researchers.
II. MATERIALS AND METHODS215
A. The VAMPIRE Dataset
The VAMPIRE Dataset and VAMPIRE Challenge were conceived during the CT ven-
tilation imaging workshop at the 2015 Annual Meeting of the American Association of
Physicists in Medicine (AAPM). Calls were put out to workshop attendees for contributions
of patient and/or animal image datasets featuring paired sets of 4DCT and RefVI scans.220
The inclusion criteria were: (i) All datasets must be anonymized and covered by existing in-
stitutional review board data-sharing arrangements, (ii) the 4DCT component must include
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at least the maximal exhale and maximal inhale phase images, (iii) the RefVI scans should
be three-dimensional volumetric images co-registered to the 4DCT, implying a focus on
well-established ventilation imaging modalities such as 99mTc SPECT/CT, 68Ga PET/CT,225
contrast enhanced (Xenon) CT, and hyperpolarized gas MRI. Contributors were requested
to suggest a journal reference for each dataset detailing the scan protocols.
A summary of the VAMPIRE Dataset, including information about the subjects and
imaging protocols is shown in Table I. Note that the tabulated values for signal-to-noise
ratio, SNR, were calculated as SNR = (µ/SD) where µ and SD are the mean and standard230
deviation of intensity values inside the lungs. For 4DCT scans the calculation was performed
for all phase images and was based on a background intensity of -1000 Hounsfield Units (HU).
For RefVI scans the calculation was based on a background intensity of zero. Details of the
lung segmentation are given in Sec. II A 4. The specific details on the three imaging studies
are given in the following subsections.235
1. Study 1 - Galligas 4DPET/CT (Human study)
Study 1 includes 25 lung cancer patients imaged with Galligas 4DPET/CT at the Pe-
ter MacCallum Cancer Centre [21, 31, 32]. Scans were acquired prior to radiation therapy
treatment on a combined 4DPET/CT scanner and in a single imaging session. All sub-
jects underwent free breathing with respiratory signals acquired using the realtime position240
management (RPM) system (Varian Medical Systems, Palo Alto, CA). The 4DCT scan
component was a low-dose cine-mode chest protocol with scans reconstructed into 5 res-
piratory phase bins with in-plane resolution 1.07 × 1.07 mm2 and slice thickness 5 mm; a
time-averaged 4DCT was also derived.
The 4DPET scan was acquired immediately following the 4DCT using 2 bed positions of 5245
minutes each. The 4DPET was reconstructed into 5 phase bins with phase-matched attenu-
ation correction from the 4DCT. The 4DPET scans had in-plane resolution 2.86×2.86 mm2,
slice thickness 3.3 mm and were inherently co-registered to the 4DCT phase images. Non-
gated (3D) Galligas PET scans were additionally derived from the time-averaged 4DPET
and thus co-registered to the time-averaged 4DCT. Based on the findings of a previous CTVI250
validation study using this same dataset [16], we performed the CTVI comparisons using
the 3D Galligas PET scans, owing to improved SNR as compared to the 4DPET scans.
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TABLE I. Summary of functional lung imaging data included in VAMPIRE. Abbreviations:
“4DCT” = four dimensional computed tomography. “PET” = positron emission tomography.
“DTPA” = diethylenetriamine pentaacetate acid. “SPECT” = single photon emission computed
tomography. “RPM” = realtime position management. “mm” = millimetres. “cm” = centime-
tres. “mA” = milliAmperes. “kVp” = kilovoltage peak. “SNR” = Signal to noise ratio. “SD”
= standard deviation. Asterisks (*) indicate where the RefVI slice thickness / in-plane resolution
were resampled to the dimensions of the 4DCT.
Study: Name: Galligas 4DPET/CT Xenon CT DTPA-SPECT
Institution: Peter MacCallum Cancer Centre University of Iowa Stanford University
Grant / Trial ID: Cancer Australia National Institutes of Health NCT01034514
(APP 1060919) (HL079406, CA166703)
Journal reference(s): [21, 31, 32] [22] [2]
Subjects: Type: Lung cancer patients Healthy sheep Lung cancer patients
# Subjects, Total: 25 4 21
# Subjects, Training: 5 1 10
# Subjects, Validation: 20 3 11
4DCT scans: Scanner type: 4DPET/CT 4DCT 4DCT
Acquisition mode: Cine Helical Cine or Helical
Breathing condition: Free-breathing Mechanical ventilation Free-breathing
Breathing signal: RPM Inflation pressure RPM
# Phase bins: 5 8 10
Slice thickness: 5.0 mm 1.0 mm 2− 3 mm
In-plane resolution: 1.07× 1.07 mm2 1.07× 1.07 mm2 0.97× 0.97 mm2
Tube voltage/current: 140 kVp / 10 mA 120 kVp / 100 mAs 120 kVp, 100 mAs/slice
SNR (mean ± SD): 1.51 ± 0.37 1.47 ± 0.10 1.63 ± 0.31
RefVI scans: Scanner type: 4DPET/CT 4DCT SPECT/CT
Imaging mechanism: Inhaled 68Ga Inhaled Xe Inhaled 99mTc
Time-delay (post 4DCT): < 10 minutes < 10 minutes 4− 5 days
Anatomic CT reference: 4DCT time average 4DCT exhale phase 4DCT time average
Axial coverage: Whole lung 3 cm Whole lung
Slice thickness: 3.27 mm 1.0 mm 8 mm *
In-plane resolution: 2.87× 2.87 mm2 1.0× 1.0 mm2 8× 8 mm2 *
SNR (mean ± SD): 2.10 ± 0.51 1.51 ± 0.13 1.89 ± 0.43
2. Study 2 - Xenon CT (Animal study)
Study 2 includes 4 healthy sheep imaged with 4DCT and Xenon CT at the University
of Iowa [22]. The sheep received computer-controlled positive pressure ventilation under255
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anaesthesia, with the pressure signal itself used for 4D phase sorting. 4DCT scans were
acquired in a helical mode and used a Siemens B30f kernel to reconstruct into 8 phase bins
with 1 mm3 voxels. Xenon CT scans were performed subsequent to each 4DCT, using the
same scanner and without moving the animal. These scans involve measurement of Xenon
wash-in and wash-out over approximately 90 breaths for a set of contiguous slices with axial260
coverage ∼ 3 cm. The Xenon CT scans were inherently co-registered to the corresponding
4DCT exhale phase image thus negating the need for a 4DCT time average image.
3. Study 3 - DTPA-SPECT/CT (Human study)
Study 3 includes 21 lung cancer radiation therapy patients receiving treatment planning
4DCT (standard-of-care) and DTPA-SPECT scans at Stanford University [2]. The 4DCT265
scans were acquired on two PET/CT scanners in either cine or helical mode, with respiratory
signals acquired using the RPM system with some patients receiving Audiovisual Biofeed-
back for breathing guidance. 4DCT scans were reconstructed into 10 breathing phase bins
and a time average with slice thickness either 2.0, 2.5 or 3.0 mm. The (mean ± SD) time de-
lay between the 4DCT and subsequent DTPA-SPECT was (4±5) days. The DTPA-SPECT270
scans included a low dose attenuation correction CT and were reconstructed into a cube of
isotropic voxel spacing 8.8 mm. In order to link each SPECT/CT with the time averaged
4DCT, a rigid registration was performed between each attenuation correction CT and the
4DCT time average using a Mattes mutual information rigid registration in Plastimatch
(http://plastimatch.org). The DTPA-SPECT scans were thus linearly interpolated to275
match the dimensions of the time averaged 4DCT.
4. Lung segmentation
A set of ‘coarse’ lung segmentations was created for each 4DCT phase image using a
region-growing method from the Insight Toolkit (ITK; see https://itk.org). Major air-
ways were additionally brushed out using ITK Snap (https://itksnap.org). The coarse280
4DCT lung masks were provided as a convenience to the Challenge participants, with the
intent that they could be (optionally) used in the participants’ own CTVI pipelines.
In order to perform the voxel-level correlation analysis between each CTVI and RefVI, a
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refined set of lung masks was subsequently produced and propagated to the RefVI as follows.
First, the coarse 4DCT masks were adjusted to exclude any voxels with CT number > −250285
HU; this was done to exclude “non-aerated” features such as vasculature, solid tumor mass,
pleural effusion etc. For the case of Xenon CT, which is inherently co-registered to the
4DCT exhale phase image, the refined exhale lung mask was propagated directly to the
Xenon CT scan using a nearest neighbour interpolation. For the case of the free-breathing
Galligas PET and DTPA-SPECT scans, which are co-registered to the time-averaged 4DCT,290
we produced time-averaged versions of the (refined) 4DCT lung masks using a “majority
vote” at each voxel. The refined, 4D time average lung masks were then propagated to the
corresponding RefVI, again via a nearest neighbour interpolation.
5. Packaging of the VAMPIRE Dataset
All of the 4DCT and RefVI datasets were converted to the Dicom and ITK MetaImage295
formats. All filenames, folder names and metadata used a straightforward alphanumeric
naming convention (e.g. the 4DCT series description is given as “AverageImage”, “Pha-
seImage XX”, or “PhaseMask XX” where “XX” represents the phase number) to facilitate
scripted CTVI generation and analysis. The dataset was packaged with a spreadsheet in-
cluding information such as the 4DCT image dimensions and voxel spacing, range of voxel300
values for the RefVI scans, and information about subject breathing patterns/manoeuvres
where available. Also included were the filenames names of the maximal exhale and max-
imal inhale 4DCT phase images based on visual inspection as well as consideration of the
segmented lung volumes.
B. The VAMPIRE Challenge305
1. Participant selection
Researchers with a known interest in CTVI (via publications, conference presentations
or personal correspondence) were invited to participate in the VAMPIRE Challenge. There
were no inclusion or exclusion criteria in terms of the choice of DIR method(s) or ventilation
metric(s).310
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2. Division of the VAMPIRE Dataset into Training and Validation components
We produced a ‘Challenge Dataset’ where the full set of 50 subjects was divided into both
a training component and a validation component, comprising an approximate 30%− 70%
split respectively. All of the 4DCT and RefVI scans were provided for the training compo-
nent, whereas only the 4DCT scans were provided for the validation component (i.e. the315
RefVI scans were blinded). The intent of the training component was to provide participants
an opportunity to perform self-evaluation and/or optimization of their CTVI algorithm(s)
prior to submitting results for the validation component. For the Galligas PET and Xenon
CT studies, none of the RefVI scans showed major imaging artefacts and so the alloca-
tion of imaging subjects to the training / validation components was performed randomly.320
For Galligas PET the split of training / validation subjects was N = 5/20 and for Xenon
CT it was N = 1/3. For the DTPA-SPECT study, the training component comprised of
N = 10 scans which were noted as having minimal radioaerosol clumping artifacts. The
remaining N = 11 had moderate clumping and were allocated to the validation component.
This choice was made to prevent participants optimizing their CTVI algorithms based on325
artefact-containing SPECT scans.
3. Instructions for Participants
Participants were instructed to download the Challenge Dataset and to generate a DIR
motion field and CTVI for each subject using the algorithm(s) and software(s) of their
choice. All CTVIs and DIR motion fields were either submitted in the ITK MetaImage330
format, or were converted to MetaImage based on provided file format documentation.
Participants were requested to use the 4DCT exhale/inhale phase images as specified in
the Challenge documentation, with the CTVI defined on the geometry of the 4DCT exhale
phase image. Participants were also requested not to apply masking or smoothing of the
output CTVIs. This was done to minimize variability due to factors other than the DIR335
method or ventilation metric. Where participants required 4DCT lung segmentations for use
in their DIR workflow, they were invited to use the segmentations provided in the Challenge
Dataset, but this was not mandatory.
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4. Characterization of CTVI algorithms
All participants were requested to complete a questionnaire to characterize their CTVI340
algorithms(s). Participants were asked details about the DIR engine(s), for example the type
of transform model (e.g. B-spline, Free-form, Diffeomorphisms or finite element modelling),
image similarity metrics (e.g. sum of squared differences, mutual information, normalized
cross correlation), the use of lung masking, motion field regularization or smoothing, and
the number of 4DCT phase images included in each DIR process (e.g. exhale/inhale only,345
or the full 4D set).
Participants were also asked to provide information about the ventilation metric(s).
Most DIR-based ventilation metrics can be categorized as evaluating breathing-induced HU
changes (“DIR-∆HU”) based on the equation developed by Guerrero et al. [5], or eval-
uating regional volume changes (“DIR-∆Vol”) based on the Jacobian determinant as per350
Reinhardt et al. [22]. Two unpublished methods evaluated both HU and volume changes
simultaneously to correct for tissue compression (“Hybrid-A”), or to determine the mechan-
ical stress distribution of the lung as a surrogate for function (“Hybrid-B”). Also considered
were “attenuation-type” ventilation metrics that do not use DIR, but rather model blood-
gas exchange in terms of time-averaged 4DCT HU values ([17]). Some ventilation metrics355
incorporate a tissue density scaling factor, ρ, which has been shown to improve the mod-
elling of radioaerosol deposition [16]. Another point of difference is that some ventilation
metrics report the ‘specific’ breathing-induced ventilation (i.e. fractional air volume change
per voxel, as in the original Guerrero equation [5]) whereas others report the ‘absolute’ air
volume change at each voxel (i.e. in units equal or proportional to mL/voxel, for example360
as used in the modified Guerrero equation [16]).
Participants were additionally asked to provide details on any pre/post-processing applied
either to the input 4DCT phase images or output CTVIs, as well as any optimization of
their algorithm(s) that was performed based on the Training scans. More information about
the ventilation metrics can be found in the Appendix.365
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5. Post-processing of participant-submitted CTVIs
All participant submitted CTVIs were resampled to the geometry of the corresponding
RefVI scan using nearest-neighbor interpolation in Plastimatch, and masked with the pre-
defined RefVI lung segmentations. Each CTVI scan was smoothed using a mask-preserving
median filter of width 3×3×3 voxels3. From earlier studies [13, 16], the 3×3×3 voxels3 filter370
was anticipated to strike a good balance between minimizing image noise whilst maintaining
the spatial fidelity of the CTVI scans. The mask-preserving median filter was chosen to avoid
any smearing between lung and non-lung voxel values. The RefVI scans were not smoothed.
In order to exclude any spurious ventilation values from the RefVIs (for example due to
radioaerosol clumping or other non-quantitive image artefacts), we used the same threshold-375
ing method applied by Kipritidis et al. [16]. That is, we applied an iterative process of: (i)
identifying and (ii) removing any RefVI lung voxels with ventilation values more than ± 4
standard deviations outside the mean for that image; this was continued until the threshold-
ing level converged to within 1%. In general the prevalence of any hotspots in the RefVIs was
low; the mean (range) of lung volume occupied by hotspots was 0.6 (0− 2.5)% for Galligas380
PET, 0.8 (0− 2.1)% for Xenon-CT and, 1.0 (0− 5.9)% for DTPA-SPECT. The same voxels
were excluded from each corresponding CTVI. Once the hotspots were excluded, four func-
tional lung zones were segmented for each CTVI and RefVI scan, : 0-25th percentile (“low
function”), 25-50th percentile (“moderate function”), 50-75th percentile (“good function”),
and > 75th percentile (“high function”).385
6. Generation of standardized CTVIs from participant-submitted DIR motion fields
For each participant-submitted DIR motion field, we used the MATLAB-based ventila-
tion toolkit, VESPIR [33], to derive “standardized” versions of the DIR-∆HU and DIR-∆Vol
ventilation metrics where they were not already available. For the purposes of this analysis,
we refer to CTVIs as being standardized if they used either the DIR-∆HU or DIR-∆Vol390
ventilation metric, reported specific ventilation at each voxel, and had no tissue density
scaling or image smoothing applied. The generation of standardized CTVIs has two advan-
tages: (i) it allows investigation of DIR motion field singularities in cases where a Jacobian
determinant image was not submitted, and (ii) it enables a more fair comparison between
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different CTVI algorithms by controlling for the many implementation differences between395
different algorithms (see Table II).
The reader should note that our definition of a standardized CTVI is arbitrary. Some
participant-submitted CTVIs will happen to fit the criteria of this definition even if they
were not specifically generated using VESPIR. At the same time, some of the VESPIR-
generated CTVIs can be described as “non-standardized,” for example where tissue density400
scaling was used.
7. Statistical analyses
Our analyses focus on the Spearman rS and the DSC, which have both been used ex-
tensively in the CTVI literature and are appropriate for comparing relative ventilation dis-
tributions in space. The Spearman rS quantifies the degree of monotonicity between two405
distributions and takes a range of values [-1,1] with -1 indicating a perfect negative corre-
lation and +1 indicating a perfect positive correlation. Unless where otherwise specified,
the rS values are calculated between pairs of spatially correlated CTVI and RefVI voxels for
the same subject. Meanwhile the DSC is used to indicate the fractional volume overlap for
a given functional percentile zone as segmented from two different ventilation images. The410
DSC takes a range of values [0,1] with 0 and 1 indicating no overlap and perfect overlap
respectively; in this work the DSC values are only computed between pairs of CTVI and
RefVI images for the same subject. All statistical analyses were performed using MATLAB
version R2015a (Mathworks Inc). We performed three specific investigations:
• Evaluating the relative ventilation distributions between CTVIs and RefVIs415
Here we compare each of the CTVIs with their corresponding RefVI scans across all
of the 34 validation subjects in the study. The different CTVI algorithms are ranked
according to the median rS and DSC values in each imaging substudy (Galligas PET,
Xenon CT and DTPA-SPECT). The results are stratified variously by (a) the choice of
DIR method, (b) ventilation metric, (c) the categorization of CTVIs as standardized or420
non-standardized, and (d) whether the CTVIs were participant-submitted or derived
from participant-submitted DIR motion fields using VESPIR. The impact of subject
selection (validation versus training subjects) is also considered. It is useful to visualize
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the data along all of these axes so as to avoid any inherent bias, especially when
comparing the participant-submitted CTVIs with those derived from the participant-425
submitted DIR motion fields.
• Evaluating the impact of DIR spatial accuracy.
In this part of the analysis we investigate possible links between the measured rS
values and the spatial accuracy of DIR. The DIR spatial accuracy is quantified in two
ways based on the AAPM Task Group 132 report on the quality assurance of image430
registration [34]. Firstly for each DIR motion field, we consider the percentage of
negative Jacobian values, J−, inside the lung volume of the 4DCT exhale phase image.
This quantity is of interest because negative Jacobian values indicate singularities in
the DIR motion field and are taken to suggest physically implausible deformations.
We note that the Jacobian determinant maps were not modified or filtered for this435
analysis.
Secondly, we assessed the DIR spatial accuracy in terms of the three-dimensional
target registration error (TRE) for anatomic landmark pairs defined on each 4DCT
exhale/inhale phase image pair. The landmark pairs are included with the VAMPIRE
Dataset and were generated using a fully-automated landmark selection method which440
is based on the scale invariant feature transform (SIFT) as implemented in Plastimatch
by Paganelli et al. [35]. The SIFT algorithm identifies and characterizes candidate
landmarks in both the exhale/inhale images using the following steps: (i) scale-space
extrema detection using a differences of gaussians technique, (ii) selection of candi-
date landmarks based on contrast and curvature thresholds, and (iii) generation of445
feature descriptors in terms of the gradient magnitude and direction. An association
is then generated between landmark pairs having similar feature descriptors, and sim-
ilar euclidean distances to neighbouring landmarks in both images. In VAMPIRE, the
SIFT landmarks were generated only within the coarse 4DCT lung segmentations de-
scribed in Sec. IIA 4. As a preprocessing step, the ITK vesselness filter was applied450
to the 4DCT exhale and inhale phase images to enhance the contrast of any tubular
structures in the lung.
Following the landmark detection process, each of the submitted DIR motion fields
was used to warp the inhale landmarks to the exhale geometry in order to compare
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TRE both before DIR and after DIR (written TREBefore−DIR and TREAfter−DIR, respec-455
tively). In order to exclude any spurious landmarks (i.e. landmarks with too much or
too little motion), we applied two levels of filtering to the detected landmark pairs: (i)
we excluded any landmarks with TREBefore−DIR smaller than the voxel spacing, and
(ii) we excluded any landmarks with TREBefore−DIR in excess of ±1.5 SD outside of the
mean for that subject. This general method was previously validated against a manual460
landmark selection method by Hegi-Johnson et al. [15]. As per the Task Group 132
report, it is expected that the TRE should be no larger than about 2mm, however in
this work we mainly use TRE to understand the relative performance of the different
DIR methods.
• Evaluating the impact of CTVI self-consistency measures.465
Here we investigate the possible links between the measured rS values and the agree-
ment between pairs of CTVIDIR−∆Vol and CTVIDIR−∆HU derived from the same DIR
motion field. In particular, we anticipate that where a CTVI indicates a true and
major ventilation defect, that there should exist a strong correlation with other ven-
tilation metrics derived from the same DIR motion field. For this analysis, we focus470
on the standardized CTVIs so as to control for the many implementation differences
between different algorithms (see Table II).
III. RESULTS
A. Summary of the CTVI and DIR motion field submissions
For the VAMPIRE Challenge, 7 participants submitted DIR motion fields based on 13 in-475
dependent DIR methods. Based on these motion fields, a total of 37 different sets of CTVIs
were submitted either directly based on participants’ in-house software (5 algorithms), or
were derived from the participant-submitted DIR motion fields using VESPIR (32 algo-
rithms). A summary of each algorithm in terms of the details of the DIR method and
ventilation metric is shown in Table II. The algorithm numbers (#) were assigned in the480
order in which the data was received and processed.
In terms of DIR method, participants used a range of commercial DIR software including
Velocity (Varian Medical Systems, Palo Alto CA) and RayStation (RaySearch Laboratories,
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TABLE II. Summary of CTVI algorithms in the VAMPIRE Challenge. Abbreviations: “DIR” =
deformable image registration. “CTVI” = computed tomography ventilation image. “Spec.” =
specific ventilation. “Abs.” = absolute ventilation. “Ex.” = exhale. “In.” = inhale. “MSE” =
mean square error. “MI” = mutual information. “CC” = cross-correlation. “NCC” = normalized
cross-correlation. “SSTVD” = squared sum of tissue volume differences. “N/A.” = not applicable.
All other abbreviations given in the text.









4DCT is CTVI is CTVI is




Plastimatch B-spline MSE X Ex/In VESPIR
DIR-∆HU
- Abs. - - -
2 X Abs. - - -
3 - Spec. - - X
4 DIR-∆Vol - Spec. - - X
5 Hybrid-A X Abs. - - -
2
6
Plastimatch B-spline MSE X Full 4D VESPIR
DIR-∆HU
- Abs. - - -
7 X Abs. - - -
8 - Spec. - - X
9 DIR-∆Vol - Spec. - - X
10 Hybrid-A X Abs. - - -
3 11 N/A N/A N/A N/A N/A VESPIR Attenuation X N/A - - -
4
12
Elastix B-spline MI X Ex/In VESPIR
DIR-∆HU
- Abs. - - -
13 X Abs. - - -
14 - Spec. - - X
15 DIR-∆Vol - Spec. - - X
16 Hybrid-A X Abs. - - -
2 5
17
Elastix B-spline NCC X Ex/In
In-house
DIR-∆HU
- Spec. X X -
18
VESPIR
- Spec. - - X
19 DIR-∆Vol - Spec. - - X
3 6
20 MORFEUS
Biomech. Contours X Ex/In
In-house Hybrid-B X N/A X X -
21 (Custom)
VESPIR
DIR-∆HU - Spec. - - X
22 DIR-∆Vol - Spec. - - X
4 7
23
In-house B-spline SSTVD X Ex/In
VESPIR DIR-∆HU - Spec. - - X
24 In-house DIR-∆Vol - Spec. - - X
5 8
25
Velocity B-spline MI - Ex/In
VESPIR DIR-∆HU - Spec. - - X
26 In-house DIR-∆Vol - Spec. - - X
6 9
27
ANTS Diffeo. CC X Ex/In
In-house DIR-∆HU
- Spec. - - X
28 X Spec. - - -




Free-form CC - Ex/In VESPIR
DIR-∆HU - Spec. - - X
31 (Standard) DIR-∆Vol - Spec. - - X
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32 MORFEUS
Biomech. Contours X Ex/In VESPIR
DIR-∆HU - Spec. - - X






DIR-∆HU - Spec. - - X
35 (Lung + ROI) +CC DIR-∆Vol - Spec. - - X
13
36 ANACONDA
Free-form CC - Ex/In VESPIR
DIR-∆HU - Spec. - - X
37 (Lung) DIR-∆Vol - Spec. - - X
Stockholm, Sweden), as well as open source DIR software including Plastimatch (http:
//plastimatch.org), Elastix (http://elastix.isi.uu.nl) and Advanced Normalization485
Tools (ANTs, http://stnava.github.io/ANTs/). The Velocity, Plastimatch and Elastix
DIR all used B-spline based transform models, whereas ANTs used diffeomorphisms. Of the
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two distinct DIR engines in Raystation, MORFEUS is a biomechanical model-based DIR
that models the lungs and body as tetrahedral-elements and applies boundary conditions on
the chest wall [36], and ANACONDA is essentially a free-form transform using a correlation490
coefficient based on image similarity [37]. Within ANACONDA we can distinguish a ‘Lung’
option which applies a varied correlation coefficient to allow larger deformations typically
seen in lungs. Additionally the ‘Lung + ROI’ option uses the same correlation coefficient as
for the ‘Lung’ setting, plus controlling contours to penalize contour variations between the
registered images. One participant also used a custom version of the MORFEUS algorithm495
that incorporates boundary conditions on the lung vessel tree [38].
Where the DIR cost function incorporated image similarity metrics, these were based on
the intensity mean square error (MSE), cross correlation (CC), squared sum of tissue volume
differences (SSTVD), or mutual information (M). All of the DIR methods used some form
of motion field regularization to avoid non-physical folding of tissue (i.e. negative values of500
the Jacobian determinant), and a majority of DIR methods also used a “lung focus” (that
is, where the DIR optimizer focuses on the lung voxels and/or lung contours). All but one
of the DIR methods used the 4DCT exhale/inhale phase images only.
In terms of ventilation metrics, the CTVIs for participants #1 and #7 were all derived
from DIR motion fields using VESPIR. By comparison participants #2-6 submitted at505
least one set of CTVIs generated using in-house software other than VESPIR. The most
commonly used ventilation metrics were different implementations of DIR-∆HU and DIR-
∆Vol (comprising around 54% and 30% of all CTVIs respectively). Approx. 65% of all
CTVIs were classified as “Standardized” as they reported the specific ventilation using
either the DIR-∆HU or DIR-∆Vol metrics with no tissue density scaling. Only two of the510
participants (#2 and #3) reported performing any optimization of their CTVI algorithms
based on the Training component of the Challenge Dataset.
In terms of the study completion rate, participants #1-6 successfully generated DIR
motion fields and CTVIs for all 50 of the VAMPIRE Dataset subjects. Participant #7
encountered errors at the DIR stage for some of the subjects; algorithms #30-33 failed for a515
single Galligas PET subject, algorithms #30-31 failed for a single SPECT subject and #34-
37 failed for all of the Xenon subjects. None of the participants applied explicit smoothing to
their submitted CTVIs. For participant #2 (algorithm #17) and participant #3 (algorithm
#20) however, smoothing filters of size 5-10 voxels3 were applied to the input 4DCT phase
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images and these smoothed phase images were propagated through to the CTVI calculation;520
this could be considered an ‘implicit’ form of CTVI smoothing.
B. Visual comparisons of CTVIs with RefVI scans
The visual agreement between CTVI and RefVI relative ventilation distributions is ob-
served to vary markedly between different algorithms and between different imaging subjects.
As an example, the upper left panel of Fig. 1 shows the coronal view of a RefVI scan for525
one of the Galligas PET validation subjects. The subject has an emphysematous region in
the right upper lobe (RUL) and a clipped artery with bleeding visible as a high CT number.
The RefVI is displayed as an amber colour wash superimposed on the 4DCT exhale phase
image, with a [window/level] setting of [0.5/1.0] after normalization to the 90th percentile
ventilation in the lung. Similarly the other 37 panels show all of the CTVIs for this same530
patient, with the algorithm # indicated in top-right corner. Each CTVI was normalized
in the same method as the RefVI scan to provide a similar visual contrast in terms of the
relative ventilation distributions.
We can see immediately that the character of each CTVI is quite different. Due to the
use of DIR motion field regularization, many of the DIR-∆Vol based algorithms (#4, 9, 15,535
22, 24, 26, 31, 33, 35 and 37) take on a smooth appearance compared to the DIR-∆HU,
Hybrid A/B or Attenuation CTVIs which all incorporate HU information directly. Some
exceptions include algorithms #17 and #20, which used the DIR-∆HU and Hybrid-B metrics
respectively and applied filtering to the input 4DCT phase images. Meanwhile algorithm
#29 uses the DIR-∆Vol method but appears less smooth due to the highly localized nature540
of the transformations produced by the diffeomorphic DIR method. For this subject the
majority of CTVIs show reasonably good concordance in terms of the RUL defect, though
for some CTVI algorithms a spurious ventilation defect is also observed in the right lower
lobe (RLL).
Figure 2 shows axial views for one of the mechanically-ventilated sheep imaged with545
Xenon CT. In this case the RefVI shows a normal Anterior-Posterior (AP) gradient with
no clear ventilation defect; here the AP gradient is likely gravity-induced. The CTVIs are
largely concordant with the RefVI in terms of the AP gradient, however once again the
character of each CTVI is unique. A common feature among the DIR-∆HU based images
22
















#1 #2 #3 #4 #5 #6 #7 #8 #9 
#10 #11 #12 #13 #14 #15 #16 #17 #18 #19 
#20 #21 #22 #23 #24 #25 #26 #27 #28 #29 




FIG. 1. Comparison of RefVI scans and corresponding CTVIs submitted for the VAMPIRE Chal-
lenge. This example shows coronal views of a human subject imaged with Galligas PET. The
CTVIs and RefVIs are all separately normalized to the 90th percentile ventilation in the lung,
with a [window/level] of [0.5/1.0] applied to all images.
Sheep subject, Xenon CT: 
#30 #31 #32 #33 #34 #35 #36 #37 
#20 #21 #22 #23 #24 #25 #26 #27 #28 #29 
#10 #11 #12 #13 #14 #15 #16 #17 #18 #19 
#1 #2 #3 #4 #5 #6 #7 #8 #9 
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FIG. 2. Comparison of RefVI scans and corresponding CTVIs submitted for the VAMPIRE Chal-
lenge. This example shows axial views of a mechanically ventilated sheep imaged with Xenon CT.
The CTVIs and RefVIs are all separately normalized to the 90th percentile ventilation in the lung,
with a [window/level] of [0.5/1.0] applied to all images. Note that the CTVIs for algorithms #34-37
are not available since the DIR could not be completed (“DNF” in the figure).
is a slight lateral streaking which may be due to streak-type reconstruction artefacts in the550
4DCT phase images. For this subject the DIR operation for algorithms #34-37 could not
be completed and so the CTVIs are not available.
Finally in Fig. 3 we see a coronal view for one of the training subjects, a lung cancer
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Human subject, DTPA-SPECT: 
#30 #31 #32 #33 #34 #35 #36 #37 
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FIG. 3. Comparison of RefVI scans and corresponding CTVIs submitted for the VAMPIRE Chal-
lenge. This example shows coronal views of a human subject imaged with DTPA-SPECT. The
CTVIs and RefVIs are all separately normalized to the 90th percentile ventilation in the lung, with
a [window/level] of [0.5/1.0] applied to all images.
patient imaged with DTPA-SPECT. Here the RefVI scan exhibits defects in both the left
upper lobe (LUL) and RUL. Some clumping is visible around the right middle lobe (RML)555
but this was noted as non-severe. Unlike in Figs. 1 or 2, here the different CTVIs tend
to bare very little resemblance either to the RefVI or each other. Only a small number of
CTVIs (e.g. algorithms #5, 11 and 20) show a ventilation defect in either of the upper lung
lobes. In fact several algorithms (e.g. #4, 9, 17, 22, 24, 26, 31, 35 and 37) show spuriously
high ventilation in the upper lung. A number of CTVI pairs appear very different despite560
being derived from the same DIR motion fields (e.g. # 21 and 22, 30 and 31, 32 and 33).
C. Evaluating the relative ventilation distributions between CTVIs and RefVIs
1. Spearman rS values
The box plots in Figures 4-7 show the distributions of rS values evaluated between all
CTVIs and their corresponding RefVI scans, where the CTVI algorithms are categorized565
according to DIR method (Fig. 4), ventilation metric (Fig. 5), standardization (Fig. 6)
or submission type (i.e. participant-submitted or derived from participant-submitted DIR
motion fields; Fig. 7). Each boxplot corresponds to a single algorithm # and imaging
















CTVI algorithms categorized by DIR type: 
B-spline / Free-form Diffeo. BM No DIR 
FIG. 4. Boxplots showing the distributions of Spearman rS values evaluated between each CTVI
and the corresponding RefVI. Each boxplot refers to a specific CTVI algorithm # and imaging
substudy (Galligas PET, Xenon CT or DTPA-SPECT). Within each subject cohort, the CTVI
algorithms are ranked in descending order from left-to-right based on the median value of rS. Here
the CTVI algorithms are categorized by the DIR method.
N =20, 3 or 11 validation subjects respectively. For each box the upper, middle and lower570
edges show the upper, middle and lower quartiles with whiskers extending out to 1.5 times
the interquartile range; outliers are indicated by ‘+’ symbols. In each panel the CTVI
algorithms are ranked in descending order from left-to-right based on the median value of
rS. We note that Figs. 5-7 show an identical set of rS values as for Fig. 4, aside from the
different CTVI categorization.575
The rS values in Fig. 4 vary markedly between different CTVI algorithms, different
imaging studies and different subjects within each study. Taking into account all 34 vali-
dation subjects, the overall highest rS values were achieved by algorithm #20, which used

















CTVI algorithms categorized by ventilation metric: 
Hybrid-A / B / Attenuation 
FIG. 5. Boxplots showing the same distributions of Spearman rS values as for Fig. 4, but with the
CTVIs categorized by the ventilation metric.
achieved rS values with an overall median (range) of 0.49 (0.27-0.73). The second highest580
ranked algorithm was algorithm #17, which used B-spline DIR with a non-standardized
DIR-∆HU ventilation metric and achieved 0.38 (-0.10 - 0.65). The third highest ranked
algorithm was algorithm #11, which did not use DIR and had an overall median (range) of
0.37 (-0.20-0.60).
The rankings for median rS values change somewhat when considering the validation585
subjects on a per-study basis. Notably, algorithm #20 performed worse for the sheep study
(median r = 0.28) than for the human studies (combined median r = 0.51). A similar
pattern was observed for algorithm #33, which also used a biomechanical model-based DIR.
Conversely, the non-DIR algorithm #11 performed better for the sheep subjects (median
r = 0.52) than for human subjects (combined median r = 0.36).590
At the lower end of the performance range, the smallest median rS value was -0.04 (-0.40-
0.34), exhibited by algorithm #22. This used the same Biomechanical DIR as algorithm
















CTVI algorithms categorized by “standardization”: 
Standardized Non-standardized. 
FIG. 6. Boxplots showing the same distributions of Spearman rS values as for Fig. 4, but with the
CTVIs categorized by the standardization type.
#20, all of the algorithms exhibited at least one negative correlation across all 34 validation
subjects. The negative correlation values occurred predominantly within the two human595
studies; by comparison the sheep study yielded only one negative correlation across all of
the CTVIs (algorithm #33).
Comparing the standardized versus non-standardized CTVIs in Fig. 6, the rankings
appear skewed towards non-standardized CTVIs in the top 10 rankings in each subject group.
The rankings appear less skewed in Fig. 7, when comparing the participant-submitted600
CTVIs versus CTVIs derived from the participant-submitted motion fields.
2. DSC values for high and low function lung
Qualitatively, we observe that the DSClow and DSChigh values show a similar level of
variability to the rS values plotted in Figs. 4-7. So as not to replicate the plots, we have not
















Derived from user-submitted DIR Participant-submitted 
CTVI algorithms categorized by submission-type:
 
FIG. 7. Boxplots showing the same distributions of Spearman rS values as for Fig. 4, but with the
CTVIs categorized by the submission type.
as for the rS data.
We observed that algorithm #20 achieved the highest overall performance across all 34
validation subjects with a median (range) of 0.52 (0.36-0.67) for DSClow and 0.45 (0.28-0.62)
for DSChigh. The second highest overall ranking was algorithm #17 for DSClow with 0.47
(0.22 - 0.66), and algorithm #11 for DSChigh with 0.43 (0.17 - 0.59). For DSClow the third610
highest ranking was algorithm #11 (median value 0.41) and for DSChigh it was algorithm
#10 (median value 0.41).
Similar to the rS data, the performance of certain algorithms changed markedly between
different subject groups. For example in terms of DSClow values, algorithms #20 and #33
were among the top 4 ranked results for Galligas PET and DTPA-SPECT, but were in615
the bottom 6 results of those provided for Xenon-CT. Also similar to the rS data, the top
10 DSC values for the different subject groups appeared skewed towards non-standardized
CTVIs over standardized CTVIs.
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Algorithm ranking (Training subjects; N=16)
















































FIG. 8. Demonstrating the impact of subject selection on CTVI algorithm rankings for rS, DSClow
and DSChigh. Each datapoint represents a single algorithm ranked seperately for the training
subjects (horizontal axis) and validation subjects (vertical axis). Each algorithm is additionally
given an “overall” rank obtained by taking an average of the rankings for the rS, DSClow and
DSChigh metrics. Note that all numeric values in this Figure refer to algorithm rank, not the
algorithm ID.
3. Considering the impact of subject selection
It is worth comparing the impact of subject selection on the correlation of relative ven-620
tilation distributions between the CTVIs and RefVIs. This is particularly the case for the
DTPA-SPECT substudy, where the training subjects were judged to have RefVI scans with
non-severe clumping, as opposed to the validation subjects who had RefVI scans with mod-
erate (or worse) clumping. Focusing only on the DTPA-SPECT study, the median (range)
of rS values across all CTVI algorithms was 0.15 (-0.39 0.71) for training subjects and 0.13625
(-0.33 0.73) for validation subjects. Extending this across all three of the Galligas PET,
Xenon CT and DTPA-SPECT studies, the mean (range) rS values changed only slightly;
from 0.18 (-0.39 0.71) for training subjects to 0.17 (-0.40 0.76) for validation subjects.
By comparison, subject selection can have a very marked effect when considering the
individual algorithm rankings. This is shown in Fig. 8, where each datapoint represents a630
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single algorithm ranked separately for the training subjects (horizontal axis) and validation
subjects (vertical axis). The separate plots for the rS, DSClow and DSChigh comparison
metrics have a zig-zag appearance where the rank for any given algorithm can change by as
many as ±10 places between the different subject cohorts. Each algorithm is additionally
given an “overall” rank obtained by taking an average of the rankings for the rS, DSClow and635
DSChigh metrics. The overall rank appears less sensitive to subject selection with a nearly
monotonic relationship.
D. Evaluating the impact of DIR spatial accuracy.
As a self-consistency measure we analyzed the percentage of negative Jacobian values,
J−, associated with each DIR motion field. We did not note any major issues with the DIR640
in this respect. Referring to the DIR method # from Table II, we found that DIR methods
#1, 4, 7-10, 12 and 13 were all completely free of negative Jacobian values within the exhale
lung volume for any of the validation subjects. DIR methods #2, 5, 6 and 11 exhibited at
most 1.3% negative Jacobian values for any single validation subject and for methods #2, 5
and 12 the mean percentage across all validation subjects was still zero. We posit that the645
small number of negative Jacobian values observed are an artefact of our (VESPIR-based)
method for generating the standardized CTVIs, which involves a B-spline interpolation of
the participant-submitted DIR motion fields. Where the submitted motion fields contain
discontinuous (sliding) motion at the chest/lung boundary, the B-spline interpolation may
subsequently produce small residual errors at that lung boundary. In any case, the influence650
of negative Jacobian values in this study appears to be very small, and no statistically
significant correlations were observed between the J− values and the Spearman rS values for
any of the CTVI algorithms.
The next set of results concern the SIFT-based TRE and consider both validation and
training subjects. The (mean ± SD) number of SIFT-detected landmarks per 4DCT scan655
was (235 ± 109) for the Galligas PET subjects, (276 ± 70) for the Xenon CT subjects and
(376 ± 174) for the DTPA-SPECT subjects. For these subjects, the (mean ± SD) values for
TREBefore−DIR were (5.7 ± 1.4) mm, (5.4 ± 0.6) mm and (5.1 ± 2.5) mm respectively. One
DTPA-SPECT subject was subsequently excluded from the TRE analysis since the number
of landmarks was very low (< 10) indicating a failure of the SIFT algorithm.660
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Figure 9(a) plots the mean values of TREAfter−DIR versus TREBefore−DIR on a per motion
field basis (i.e. there are 589 data points, which corresponds to 50 subjects × 12 DIR
methods, excluding 11 cases of failed DIR). The vertical and horizontal lines indicate the
4DCT slice thicknesses for each of the different imaging studies; this should be considered
as a limiting factor in the TRE values actually observed. For the Galligas-PET and DTPA-665
SPECT subjects, the best DIR spatial accuracy was achieved by a B-spline method (DIR
method #5, corresponding to CTVI algorithms #17-19). This achieved TREAfter−DIR values
with a (mean ± SD) of (3.0 ± 1.0) mm for Galligas PET and (2.3 ± 1.1) mm for DTPA-
SPECT. For Xenon CT subjects, the best accuracy was exhibited by another B-Spline
method (DIR method #1, corresponding to CTVI algorithms #1-5), which achieved mean670
TREAfter−DIR values of (1.4 ± 0.2) mm.
With regards to the poorest performing DIR methods, for Galligas PET this was a B-
Spline method (DIR method #8), which exhibited a mean TREAfter−DIR value of 5.4 mm.
For the Xenon-CT and DTPA-SPECT studies, a Biomechanical model method (DIR method
#11) performed worst with mean TREAfter−DIR values of 3.5 mm and 4.8 mm respectively.675
Out of the 589 submitted DIR motion fields, we identified 6 motion fields yielding a mean
TREAfter−DIR value in excess of 10mm. The worst case had TREAfter−DIR ∼ 21 mm; on closer
inspection the DIR appeared to have been run in the wrong direction (i.e. Exhale → Inhale
as opposed to Inhale → Exhale). For the other 5 cases mentioned above, the fault appears
to be with the DIR algorithm itself, rather than any human error in its application.680
Figure 9(b) investigates the link between TREAfter−DIR and Spearman rS. The figure
includes 1778 data points covering all of the available CTVIs for all of the DIR-based CTVI
algorithms. Overall, we found a moderately negative correlation between Spearman rS and
TREAfter−DIR for the case of Xenon CT subjects (linear correlation -0.47, p < 0.0001), how-
ever the correlation was almost zero for the case of Galligas PET subjects (linear correlation685
-0.05, p = 0.10) and DTPA-SPECT subjects (linear correlation -0.06, p = 0.09). For some
of the CTVI algorithms using the DIR−∆Vol metric, significant negative correlations were
observed within specific subject groups: namely CTVI algorithm #26 for the Galligas PET
subjects, and CTVI algorithms #31, 35 and 37 for the DTPA-SPECT subjects. In each of
these cases the linear correlations were all within the range (-0.49,-0.45), with p = 0.02−0.05.690
No other statically significant correlations were observed between rS and TREAfter−DIR.
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(a) (b) 
FIG. 9. Investigating the impact of DIR spatial accuracy on the cross modality correlations between
CTVIs and RefVIs. The plots compare: TREBefore−DIR and TREAfter−DIR for each of the 589
submitted motion fields (left panel), and the variation of rS with TREAfter−DIR for all of the
DIR-based CTVIs (right panel).
E. Evaluating the impact of CTVI self-consistency measures.
Figure 10(a) investigates whether the rS values computed between a given CTVIDIR−∆Vol
and RefVI are related to the rS values computed between that same CTVIDIR−∆Vol and
the corresponding CTVIDIR−∆HU. In other words, each datapoint in the figure refers to a695
pair of standardized CTVIDIR−∆Vol and CTVIDIR−∆HU derived from the same DIR motion
field. Figure 10(b) performs a similar comparison but plots the vertical axis in terms of
CTVIDIR−∆HU. We observed moderate linear correlations of 0.60 for the datapoints in Fig.
10(a) and 0.50 for the datapoints in 10(b), both with p < 0.001. The implication is that,
where the relative ventilation distributions of CTVIDIR−∆Vol and CTVIDIR−∆HU correlate700
more strongly with each other, they also correlate more strongly with the RefVI scan.
IV. DISCUSSION
For the VAMPIRE Challenge, we quantified the correlation of relative ventilation distri-
butions between CTVIs and RefVIs for 37 individual CTVI algorithms based on submissions
from 7 different groups. The correlation analyses were made using the voxel-wise Spearman705
rS evaluated over the whole lung, and the DSC evaluated separately for high and low func-
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(a) (b) 
FIG. 10. Investigating self-consistency between standardized CTVIs. Here the vertical axes
show the Spearman correlation rS between each standardized CTVIDIR−∆Vol (left panel) or
CTVIDIR−∆HU (right panel) with the corresponding RefVI. The horizontal axes show the rS val-
ues calculated between each corresponding pair of CTVIDIR−∆Vol and CTVIDIR−∆HU ventilation
images derived from the same participant-submitted DIR motion field. The rP values refer to the
linear (Pearson) correlations computed from all the data points in each plot.
tion lung. A summary of the overall best performing CTVI algorithms for the three different
RefVI modalities is shown in Table III. For the nuclear medicine modalities - Galligas PET
and DTPA-SPECT - the best performing CTVI algorithm (#20) used a biomechanical-
model based DIR with maximum principle stress as the ventilation metric. Meanwhile for710
Xenon CT, the best performing CTVI algorithm (#11) computed a 4D time average of the
tissue-air product and did not use DIR at all. Paradoxically, neither of these CTVI methods
compute “ventilation” in the strict sense of breathing induced air volume changes at the
voxel level. Rather, they compute other abstracted quantities, related to tissue aeration and
tissue elasticity, which might be reasonably expected to correlate with ventilation. Since715
the various RefVI modalities also operate on fundamentally different imaging targets (i.e.
radioaerosol deposition versus gas wash-in/ wash-out), it is difficult to make a statement
about the “accuracy” of these CTVIs beyond comparing the relative distributions in space.
If the goal of CTVI is to replace a given type of RefVI for functional avoidance treatment
planning, then the level of inter-subject variability for the rS values in Figs. 4-7 is concerning.720
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TABLE III. Summary of the overall best-performing CTVI algorithms for each of the Reference
ventilation imaging modalities in VAMPIRE. Abbreviations. “BM-DIR” = Biomechanical-model
based DIR. “Max.” = Maximum. “Avg.” = Average. “N/A” = Not applicable.
RefVI modality: Type of DIR: CT ventilation metric:
Validation result (Mean ± SD)
rS : DSClow : DSChigh :
Galligas-PET BM-DIR Max. principle stress (0.53 ± 0.10) (0.53 ± 0.08) (0.47 ± 0.07)
Xenon CT N/A Time avg. tissue-air product (0.49 ± 0.13) (0.49 ± 0.08) (0.51 ± 0.08)
DTPA-SPECT BM-DIR Max. principle stress (0.49 ± 0.16) (0.52 ± 0.07) (0.45 ± 0.11)
With the exception of algorithm #20, all of the algorithms exhibited at least one rS value
less than zero (i.e. negatively correlated with the RefVI scan). Moreover in Fig. 8 we see
that the subject selection had a marked impact on the CTVI rankings in terms of the rS,
DSClow and DSChigh evaluation metrics; the implication being that a CTVI algorithm may
appear to perform “better” for some subjects than others. Based on Fig. 9(b), the rS values725
do not appear to be determined by the spatial accuracy of the DIR; indeed it is possible to
identify DIR motion fields that have a relatively large registration error whilst still yielding
CTVIs with relatively high rS. Currently we can only speculate as to why such significant
inter-patient variability was observed.
One possibility is suggested by the studies of Du et al. [27, 28] who showed that spon-730
taneous changes in breathing amplitude, frequency, and breathing mode that occur during
free-breathing can reduce the reproducibility of CTVIs generated from repeat 4DCT scans.
Unfortunately the VAMPIRE Challenge is ill-posed to deal with this question, since we do
not have adequate information to correct for breathing effort differences between the 4DCT
and RefVI scans. Since repeat (short-interval) scans were unavailable, it is impossible to de-735
termine whether the differences between CTVI algorithms were within the repeat variability
of the different methods themselves. A distinct, but related, problem is to determine the
numerical stability of each CTVI algorithm as this could be influenced by patient-specific
factors. The theoretical study by Castillo et al. [26] presented a framework for evaluating
the impact of small DIR perturbations on a resulting Jacobian-based ventilation image; they740
found it was possible to compute two DIR transformations with similar TRE yet producing
very different CTVIs. In future multi-institutional validation studies, it would be interest-
ing to quantify the uncertainty in observed rS and DSC values based on DIR perturbations
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which are comparable to the motion differences between short-interval scans. This could
provide a better understanding of the impact of stochastically varying breathing motion745
parameters.
When interpreting the observed rS and DSC distributions as ‘good’ or ‘poor’, the reader
should bear in mind that there exists little data regarding what level of rS or DSC correlations
are required to justify the use of CTVI for functionally guided radiation therapy treatments.
To our knowledge only the study by Kida et al. [10] broaches this topic. Kida et al.750
compared functional plans derived from CTVI and DTPA-SPECT for the case of 8 lung
cancer patients, where the CTVIs and SPECT ventilation scans had a mean Spearman
correlation of rS ∼ 0.4. Those authors observed acceptable agreement between the CTVI
and SPECT based functional plans in terms of the functional dose-volume parameters (e.g.
the fV20, which exhibited differences less than 4%). The study by Kida et al. is directly755
relevant to the VAMPIRE Challenge because some of their study subjects are included as
Training subjects in our DTPA-SPECT data, also the CTVI algorithm used in their study
corresponds to algorithm #17 of the VAMPIRE Challenge. Looking at the DTPA-SPECT
results in Fig. 4, we see that many CTVI algorithms did achieve r ≥ 0.4 for at least one of the
validation subjects. However, the variability of rS values also suggests that CTVI-guidance760
may not be effective or appropriate for all patients.
In this work we generated “standardized” CTVIs from the user submitted DIR motion
fields, and have proposed this as a means to overcome the large number of implementation
differences between different CTVI algorithms. However one caution with this approach is
that the non-standardized CTVIs tended to demonstrate higher cross-modality correlations765
than the standardized CTVIs (as evident from panel (c) from each of Figs. 4-6). This could
indicate some bias in the results, which could arise if a given DIR method was designed
to provide motion fields that are appropriate only to one type of ventilation metric. Addi-
tionally, our standardization technique involved a B-spline interpolation of the participant-
submitted motion fields which may have created some undesirable, albeit marginal, effects770
when applied to motion fields derived from a non B-spline DIR. For example, biomechani-
cal model based DIR will present motion field discontinuities at the sliding interface of the
lung, and this may lead to negative Jacobian values if the B-spline interpolation assumes
a smoothly motion field across the whole image. We can extend the same caution when
comparing the performance of CTVIs derived from “in-house” DIR algorithms (which are775
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easily tweaked via various user-adjustable parameters) versus commercial DIR algorithms
(which tend to have restricted access to the DIR parameters and are designed for specific
clinical applications). In particular, we point out that the biomechanical model based DIR
methods are based on human lung models, which may explain why the associated CTVI
algorithms performed better for humans than for sheep.780
One of the most interesting findings is represented by the data in Fig. 10. The data
suggest that for paired CTVIDIR−∆HU and CTVIDIR−∆Vol derived from the same DIR motion
field, the correlation of either CTVI with the RefVI tends to be higher when both CTVIs
correlate more strongly with each other. This is also evident in the visual comparisons in
Figs. 1-3, where the Galligas PET and Xenon-CT subjects have CTVIs which appear quite785
similar across many different algorithms, whereas the DTPA-SPECT subject shows CTVIs
with relatively poor agreement with each other. It seems intuitive that given a patient
with a gross ventilation defect, a high-quality 4DCT scan and spatially accurate DIR, then
the DIR-∆HU and DIR-∆Vol ventilation images should show similar localization of that
defect and that their relative ventilation distributions should be reasonably well correlated.790
By comparison, a poor correlation between paired DIR-∆HU and DIR-∆Vol ventilation
maps could indicate an issue somewhere along the image acquisition/processing chain. The
possibility of using multiple CTVIs as a form of secondary check is an interesting avenue for
future CTVI research. At any rate, the use of multiple self-consistency metrics for the DIR
and CT ventilation is recommended.795
We would like to point out some limitations of this study. First, we have not specifically
focused on the impact of different image filtering / smoothing levels on the CTVIs. While we
have made efforts to avoid additional image filtering/smoothing by the participants, it was
not possible to control this aspect completely and readers should be aware that measured rS
or DSC values will tend to increase or decrease where the CTVI smoothing filter is increased800
or decreased, respectively [16]. Second, this study did not focus on the impact of the 4DCT
or RefVI image quality (e.g. as measured using SNR). We argue that this is a reasonable
omission since, from Table I, the mean SNR values are not observed to vary drastically
across the various 4DCT or RefVI scan sets. For nuclear medicine ventilation scans, an
important type of image artefact is radioaerosol clumping which has been recognized in805
numerous CTVI validation studies. As explained in the excellent review by Schembri et
al. [25], nuclear medicine ventilation imaging may still be considered ‘robust’ despite the
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presence of clumping. This is because clumping artefacts do not reflect an uncertainty in the
technology itself, but rather have a clinical reading which is grounded in physiology and flow
dynamics. The clinical interpretation of radioaerosol clumping will depend on the physical810
properties of the radioaerosol itself, the presence of lung disease, as well as the respiratory
effort of the patient. In VAMPIRE, we applied an algorithmic approach to segmenting and
excluding clumping hotspots from our correlation analyses. On average the hotspot volume
was less than 1% of the lung volumes, and as such the impact of the hotspot segmentation
was only detectable in the second decimal place of the rS and DSC values. The authors of815
this work agree that a greater focus on image quality metrics may be of interest for future
CTVI validation studies, in particular where multiple 4DCT and/or multiple RefVI scans
are available for the same subject.
Finally, we can consider that one further limitation of this work - and to an extent
all CTVI studies - is that none of the studied ventilation modalities in this study (CTVI,820
SPECT, PET or Xenon CT) purport to distinguish between gas transport within the air
spaces of the lung, as opposed to gas exchange with the circulation. According to Simon et
al. [1], it is this latter quantity of blood-gas exchange that more correctly represents the true,
physiologic lung function. The potential significance of this distinction is shown in a recent
study by Rankine et al. [29], who found poor spatial correlation between interleaved images825
of airspace ventilation versus blood-gas transfer acquired using dissolved-phase 129Xe with
MRI. If CTVI is to successfully enable avoidance of functional lung (rather than merely
aerated or deforming lung), then it would be ideal if future CTVI validation studies can
incorporate additional types of imaging modalities - such as 129Xe MRI - that can test for
the true physiologic meaning of CTVI. On the other hand, one could argue that observing830
blood-gas exchange is not the function of ventilation imaging; for example it is a critical
and clinically ubiquitous method of diagnosing pulmonary embolism, which is essentially
ventilation / perfusion mismatch. In either case, it may be that CTVI only gives part of
the picture. Ultimately, it will remain up to the clinician to decide which type of functional
image is important to the treatment plan.835
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V. CONCLUSIONS
CT ventilation imaging (CTVI) research has focused extensively on clinical validation,
but until now there has been little in the way of common validation tools for CTVI re-
searchers. We have built VAMPIRE to address the need for a common validation dataset,
and report the results of the first multi-institutional VAMPIRE Challenge to evaluate rela-840
tive ventilation distributions between CTVI and other clinically accepted ventilation imaging
modalities. The Challenge results demonstrate that the cross-modality correlations vary not
only with the choice of CTVI algorithm, but also with the imaging subject and the type
of ventilation imaging modality used as a reference. These findings highlight the ongoing
importance of validation studies before CTVI technology can be widely translated from845
academic centers to the clinic.
APPENDIX. CLASSIFICATION OF CT VENTILATION METRICS USED IN
THE VAMPIRE CHALLENGE
DIR-based ventilation metrics
The DIR-based ventilation metrics in the VAMPIRE Challenge calculate breathing-850
induced air volume changes in terms of regional intensity changes (DIR-∆HU), regional
lung volume changes (DIR-∆Vol) or other related quantities based on hybrids of these two
approaches. The DIR-∆HU metric is based on an expression introduced by Guerrero et al.









[HU∗in(x+ v) + 1000]
where HUex(x) represents the voxels of the 4DCT exhale phase image, and where a global
intensity correction is applied to lung voxels of the deformed moving image (HU∗in) to account
for changes in blood distribution during inspiration. The DIR-∆Vol metric was introduced
by Reinhardt et al. [22] and is calculated as CTVIDIR−∆Vol = J(x,v) − 1, were J(x,v) is
the Jacobian determinant of v(x). Positive (or negative) values of CTVIDIR−∆Vol indicate860
regional lung volume expansion (or contraction). It should be noted that the voxel values
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of CTVIDIR−∆Vol do not necessarily represent the air-volume change directly, rather they
express the change in regional lung volume which is taken to be proportional to the specific
ventilation.
Two types of hybrid CTVI algorithm were also used in the VAMPIRE Challenge. The865
Hybrid-A calculation is a modification of the original DIR−∆HU equation, and performs a
density correction for each voxel of HUex(x) to account for tissue compression using J(x,v).
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Meanwhile the Hybrid-B method incorporates a custom version of the MORFEUS DIR870
algorithm [38] where each tetrahedral element in the model is assigned a Young’s modulus
following a linear function of HU in the lung inhale CT scan. The ventilation is modeled as
the maximum principal stress computed for each tetrahedral element.
Non DIR-based ventilation metric
The “Attenuation” metric was developed in Ref. [17] and is based on the assumption875
that physiological ventilation (i.e. blood-gas exchange) should relate to the regional product
of tissue and air densities. The CTVI is calculated directly from 4DCT HU values which
























the fractional tissue-content. Any voxels with HU values HU > 0 or HU < −1000 are set880
to zero. Since the CTVIAttenuation method does not account for the 4D motion of each lung
tissue element, it can be expected to exhibit generally poor spatial accuracy. In effect, the
spatial resolution of this CTVI method is as coarse as the 4D lung motion itself.
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Scaling factors
There are a few possible ventilation scaling factors to be aware of. The DIR-∆HU, DIR-885
∆Vol and Hybrid-A methods as described all calculate the specific (fractional) ventilation
at each voxel. This may be converted to an absolute ventilation in units proportional to
mL/voxel by multiplying each voxel by its volume of air at exhale, HUex(x)
−1000
× Volx, where
Volx is the volume of the voxel at x. By comparison, the ventilation distributions produced
by the Hybrid-B and Attenuation metrics do not represent air volume directly and so we890
avoid the use of the “specific” or “absolute” ventilation descriptors.





which takes a value in the range [0,1] and has been shown to improve the modelling of
radioaerosol deposition when applied to the standard DIR-∆HU and DIR-∆Vol metrics
[16]. The ρex(x) term appears in the calculation of the CTVIAttenuation images and is also
implicit in the calculation of the Youngs modulus for the Hybrid-B metric.895
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